Imagine the heart as a pump with internal supports that get pulled out of place after a heart attack, making the pump leak. Current surgeries only help the few with the worst leaks, leaving most people with no options. This device acts like a tiny internal sling that pulls those supports back into place using a thin tube, avoiding open-heart surgery.
80% of heart failure patients do not have severe enough symptoms for traditional surgery but still deteriorate and face death because no device-based treatments exist for their specific condition.
A transcatheter ventricular repair system consisting of a V-sling implant and a catheter delivery system, fully optimized and pre-clinically validated.
If you are a medical device company dealing with a lack of treatments for non-severe heart failure — this project developed a transcatheter ventricular repair system that targets the 80% of patients currently ignored by surgery.
If you are a hospital dealing with high mortality in heart failure patients who don't qualify for transplants — this project developed the V-sling system that improves cardiac function via a transcatheter procedure.
If you are a research organization dealing with the need for First-in-Human (FIH) study management — this project developed a validated implant and delivery system ready for human testing.
Based on available project data, there is no specific pricing or cost per unit mentioned.
The project has finalized design optimization and completed verification and validation testing, suggesting it is moving toward production readiness.
Based on available project data, specific patent numbers or licensing terms are not provided, though the project is led by an SME, Cardiac Success Ltd.
The project has completed V&V testing and chronic in-vivo pre-clinical testing to ensure safety and efficacy before human trials.
The project period runs from 2022-05-01 to 2026-04-30, with the final objective being the First-in-Human (FIH) study.
The project is managed by a single-partner consortium consisting of one Israeli SME, Cardiac Success Ltd. This 100% industry-led structure indicates a strong focus on commercialization and direct product development rather than academic research.
Contact Cardiac Success Ltd in Israel
Contact us to explore licensing opportunities for the V-sling system.
